Astilbin improves the therapeutic effects of mesenchymal stem cells in AKI-CKD mice by regulating macrophage polarization through PTGS2-mediated pathway
Abstract Background Although mesenchymal stem cells (MSCs) have been proven to be appropriate candidates for the treatment of AKI-CKD, their efficacy is limited and variable. Astilbin (AST) had a protective effect on MSCs from oxidative stress via ROS-scavenging, however, whether it can improve MSCs...
Saved in:
| Main Authors: | Xiaodong Geng, Zhangning Fu, Guangrui Geng, Kun Chi, Chao Liu, Haijuan Hong, Guangyan Cai, Xiangmei Chen, Quan Hong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | Stem Cell Research & Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13287-024-04025-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circadian Clock Gene Bmal1: A Molecular Bridge from AKI to CKD
by: Songyuan Yang, et al.
Published: (2025-01-01) -
Mechanistic insights and therapeutic potential of astilbin and apigenin in diabetic cardiomyopathy
by: Sachin Dhiman, et al.
Published: (2024-11-01) -
FUT8 upregulates CD36 and its core fucosylation to accelerate pericyte-myofibroblast transition through the mitochondrial-dependent apoptosis pathway during AKI-CKD
by: Yaxi Shang, et al.
Published: (2024-11-01) -
Profile of renal conditions among pediatric emergency patients
by: Noha El-Anwar, et al.
Published: (2024-12-01) -
Incidence, risk factors, and outcomes of the transition of HIPEC-induced acute kidney injury to acute kidney disease: a retrospective study
by: Yunwei Lu, et al.
Published: (2024-12-01)